Related Experiment Video
Updated: Nov 22, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
Reciprocal Induction of MDM2 and MYCN in Neural and Neuroendocrine Cancers
Hung N Tran1, Hardeep P Singh2,3,4, Wenxuan Guo2,3,5
1Division of Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, CA, United States.
Abstract:
MYC family oncoproteins MYC, MYCN, and MYCL are deregulated in diverse cancers and via diverse mechanisms. Recent studies established a novel form of MYCN regulation in MYCN-overexpressing retinoblastoma and neuroblastoma cells in which the MDM2 oncoprotein promotes MYCN translation and MYCN-dependent proliferation via a p53-independent mechanism. However, it is unclear if MDM2 also promotes expression of other MYC family members and has similar effects in other cancers. Conversely, MYCN has been shown to induce MDM2 expression in neuroblastoma cells, yet it is unclear if MYC shares this ability, if MYC family proteins upregulate MDM2 in other malignancies, and if this regulation occurs during tumorigenesis as well as in cancer cell lines. Here, we report that intrinsically high MDM2 expression is required for high-level expression of MYCN, but not for expression of MYC, in retinoblastoma, neuroblastoma, small cell lung cancer, and medulloblastoma cells. Conversely, ectopic overexpression of MYC as well as MYCN induced high-level MDM2 expression and gave rise to rapidly proliferating and MDM2-dependent cone-precursor-derived masses in a cultured retinoblastoma genesis model. These findings reveal a highly specific collaboration between the MDM2 and MYCN oncoproteins and demonstrate the origin of their oncogenic positive feedback circuit within a normal neuronal tissue.
Insights
MDM2 protein specifically promotes MYCN expression in several cancers, forming an oncogenic feedback loop. This collaboration is essential for tumor growth and originates in normal neuronal tissue.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- MYC family oncoproteins (MYC, MYCN, MYCL) are frequently deregulated in various cancers.
- MDM2 (mouse double minute 2 homolog) oncoprotein promotes MYCN translation and proliferation independently of p53 in retinoblastoma and neuroblastoma.
- The roles of MDM2 in regulating other MYC family members and its involvement in tumorigenesis remain unclear.
Purpose of the Study:
- To investigate if MDM2 regulates other MYC family members beyond MYCN.
- To determine if MYC family proteins upregulate MDM2 expression in various cancers and during tumorigenesis.
- To elucidate the specific collaboration between MDM2 and MYC/MYCN oncoproteins.
Main Methods:
- Analysis of MDM2 and MYCN expression in retinoblastoma, neuroblastoma, small cell lung cancer, and medulloblastoma cell lines.
- Overexpression studies of MYC and MYCN in a cultured retinoblastoma genesis model.
- Assessment of MDM2 dependency for proliferation in induced tumor masses.
Main Results:
- Intrinsically high MDM2 expression is crucial for high-level MYCN expression, but not MYC, across multiple cancer types.
- Ectopic MYC and MYCN overexpression induce high-level MDM2 expression.
- Induced MYC/MYCN overexpression leads to rapid proliferation and MDM2-dependent tumor formation in a retinoblastoma genesis model.
Conclusions:
- MDM2 and MYCN oncoproteins exhibit a highly specific collaborative relationship.
- An oncogenic positive feedback circuit between MDM2 and MYCN originates within normal neuronal tissue.
- This specific interaction is a key driver in certain malignancies, particularly those involving MYCN.
Related Concept Videos
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Master Transcription Regulators
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...

